Showing results (71-80 of 249) with videos related to
Sort By:
Pageof 25
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2009
Hepatitis C infection and chronic renal diseasesNorberto Perico, Dario Cattaneo, Boris Bikbov, et al.Kidney International. Supplement|December 13, 2005
The role of renin-angiotensin-aldosterone system in the progression of chronic kidney diseaseGiuseppe Remuzzi, Norberto Perico, Manuel Macia, et al.Nature Reviews. Nephrology|February 9, 2016
Mesenchymal stromal cells in renal transplantation: opportunities and challengesFederica Casiraghi, Norberto Perico, Monica Cortinovis, et al.The Lancet. Infectious Diseases|August 28, 2022
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agentsNorberto Perico, Monica Cortinovis, Fredy Suter, et al.Contributions to Nephrology|August 3, 2021
COVID-19 and the Kidney: Should Nephrologists Care about COVID-19 rather than Maintaining Their Focus on Renal Patients?Norberto Perico, Luca Perico, Claudio Ronco, et al.Nature Reviews. Nephrology|September 19, 2018
Maternal and environmental risk factors for neonatal AKI and its long-term consequencesNorberto Perico, David Askenazi, Monica Cortinovis, et al.Journal of Chromatographic Science|July 24, 2008
Determination of atazanavir in human plasma by high-performance liquid chromatography with UV detectionDario Cattaneo, Franco Maggiolo, Diego Ripamonti, et al.Nephron|May 18, 2026
Immunosuppressive strategies in kidney xenotransplantation with an emphasis on complement inhibitionFederica Casiraghi, Nadia Azzollini, Giuseppe Remuzzi, et al.The Lancet. Infectious Diseases|December 20, 2008
Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsisDaniele Poole, Guido Bertolini, Silvio GarattiniEuropean Journal of Clinical Pharmacology|September 21, 2002
Fluoxetine dose and outcome in antidepressant drug trialsCorrado Barbui, Matthew Hotopf, Silvio GarattiniPageof 25